X

Stock Analysis

Evaluated by users | BSE: | NSE: |
Calyx Chemicals and Pharmaceuticals Limited was originally incorporated as Shree Deep Jyote Industrial Paints Private Limited on January 14, 1986 .The company’s name was changed to Calyx Chemicals and Pharmaceuticals Private Limited. The company was converted into a public limited...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.
Key Financial Ratios
No Data To Display
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Calyx Chemicals and Pharmaceuticals Limited was originally incorporated as Shree Deep Jyote Industrial Paints Private Limited on January 14, 1986 .The company’s name was changed to Calyx Chemicals and Pharmaceuticals Private Limited. The company was converted into a public limited company and consequently the name of the company was changed to Calyx Chemicals and Pharmaceuticals Limited.

The company was originally promoted by Dharmesh Shah and Satyen Shah

Calyx Chemicals and Pharmaceuticals Limited was originally incorporated as Shree Deep Jyote Industrial Paints Private Limited on January 14, 1986 .The company’s name was changed to Calyx Chemicals and Pharmaceuticals Private Limited. The company was converted into a public limited company and consequently the name of the company was changed to Calyx Chemicals and Pharmaceuticals Limited.

The company was originally promoted by Dharmesh Shah and Satyen Shah inter alia to manufacture, produce, refine, recover, extract, distil, concentrate, dilute, rectify, convert, buy, sell, export, import or otherwise deal in all types of paints, synthetic paints and thinners, colored or other cements, varnishes, synthetic resins, enamel, lacquers, distempers, disinfectants, oils, wood preservative, fruit or vegetable or other preservatives, printing and making inks, dry inks, writing inks, polishes of description including metal, wood, paper, polishes, crayons, powders, electroplating, abrasive and its chemicals, shoe dressing, greases, Vaselines, creams, glue, gelatine and other glue preparations and allied products, methylated and rectified spirits, dry or other colours, water dyes, die intermediates, pigments dyes, all type of turpentine including Canada turpentine from fine larchfir, nstalmen and other trees.

The Promoter-Directors, Smitesh Chandravadan Shah and Bharat Sukhlal Mehta along with Indulal Dalichand Doshi acquired this company in the year 1995. Subsequently, the business objects were changed to include the manufacture and sale of pharmaceutical products and the company’s name was changed to Calyx Chemicals and Pharmaceuticals Private Limited accordingly. In the year 2004, the company acquired the properties and assets of Indi Systems. In the year 2006, Calyx Pharmaceuticals and Chemicals Private Limited (a company promoted by Smitesh Chandravadan Shah, Bharat Sukhlal Mehta and Indulal Dalichand Doshi) merged with Calyx Chemicals and Pharmaceuticals Private Limited. Pursuant thereto and upon conversion into a public limited company, the company is presently named Calyx Chemicals and Pharmaceuticals Limited.

Smitesh Chandravadan Shah, Chairman and Managing Director, is a commerce graduate and has been closely associated with the pharmaceutical industry for over 30 years. He is currently the Chairman of The Pharmaceutical Export Promotion Council of India (Pharmexcil) and in the past, has held prestigious positions such as Honorary General Secretary of Indian Drugs Manufacturers Association (IDMA) and Senior Vice President of the Bulk Drugs Manufacturers Association (BDMA). Dr. Bansi Lal, President and Head of Department, R & D, has more than 35 years of experience in new drug discovery, has published 56 papers (national and international journals) and has 56 patents to his credit in India and abroad.

Business Overview:

The company is a manufacturer of Active Pharmaceutical Ingredients and Intermediates in India with strong presence in the manufacture of macrolides, anti- tuberculosis and anti-depressants and increasing focus on CRAMS to transnational pharmaceutical companies. The company has, over the years, moved from a single product (Anti TB - Pyrazinamide) to a multi-product portfolio comprising Anti-TB, Macrolides, Anti-Depressants, Anti-Hypertensives and Anti-Malarial (the products business).The company has also spent a substantial part of its efforts in the last 5-6 years in creating a strong base for theCRAMS business:

  • The company serves markets in 48 countries around the globe and has a team of 26 sales representatives and agents
  • The company has signed over 100 Confidentiality Agreements (CDA s) with various trans-national pharmaceutical companies

These developments have enabled the company to make inroads into the high growth, high margin CRAMS business apart from its established Products business. The company is managed by a team of experienced and professional personnel with exposure in various aspects of pharmaceutical industry including production, research and development, marketing and finance.

The Business segments:

The business of the company broadly comprises of the following segments:

  • Products business
  • Contract Research and Manufacturing Services (CRAMS)

Group Companies:

Private companies

  • Top Brass Gifts Private Limited
  • Noble Tele Infotech Private Limited
  • Noble Strategies Private Limited
  • Advanced Digital Software Private Limited
  • Adage Systems Private Limited


Limited liability partnership firms

  • MSD Trading LLP

Partnership firms

  • Sum Electronics

Sole proprietorships

  • M/s Paras Trading Corporation-
  • M/s Bharat S. Mehta
  • M/s Asha B. Mehta

HUFs

  • Bharat Mehta HUF

Major Events:

  • 1979 - Smitesh Chandravadan Shah starts business under the name and style of Calyx Chemicals, a sole proprietorship for the manufacture of pharmaceutical products
  • 1986 - Dharmesh Shah and Satyen Shah incorporate Shree Deep Jyote Industrial Paints Private Limited a private limited company incorporated under the laws of India
  • 1994 - Calyx Chemicals is converted into a partnership constituted by Smitesh Chandravadan Shah, Bharat Sukhlal Mehta and Indulal Dalichand Doshi
  • 1995 - Calyx Pharmaceuticals and Chemicals Private Limited were incorporated to take over the business of Calyx Chemicals
  • 1995 - Smitesh Chandravadan Shah, Bharat Sukhlal Mehta and Indulal Dalichand Doshi acquire Shree Deep Jyote Industrial Paints Private Limited. It is renamed as Calyx Chemicals and Pharmaceuticals Private Limited
  • 1998 - Calyx Chemicals and Pharmaceuticals Private Limited expanded its manufacturing unit at Tarapur
  • 2004 - Calyx Chemicals and Pharmaceuticals Private Limited acquired the assets and properties of Indi Systems, a partnership firm
  • 2004 - Indulal Dalichand Doshi transfers his controlling shareholding in company to his son, Rajat Indulal Doshi, who subsequently becomes a promoter of company
  • 2005 - The capacity of manufacturing unit at Tarapur is expanded with the addition of 2 manufacturing facilities
  • 2005 - Calyx Chemicals and Pharmaceuticals Private Limited acquired property located at Unit Number 2 on the ground floor of the Marwah’s Complex, Marwah Industrial Estate, Saki Vihar Road, Sakinaka, Andheri (East), Mumbai-400 072
  • 2006 - Calyx Chemicals and Pharmaceuticals Private Limited and Calyx Pharmaceuticals and Chemicals Private Limited are merged vide order of the High Court of Judicature at Bombay dated April 19, 2006 in Company Petition No. 100 of 2006 connected with company Application No. 132 of 2006 and company Petition No. 101 of 2006 connected with Company Application No. 133 of 2006
  • 2006 - Pursuant to the amalgamation of Calyx Chemicals and Pharmaceuticals Private Limited with Calyx Pharmaceuticals and Chemicals Private Limited, the company acquired control of manufacturing unit at Dombivli
  • 2006 - Calyx Chemicals and Pharmaceuticals Private Limited is converted into a public limited company
  • 2010 - Equity Investment by Lytton Grove Corporation, Panama by way of acquisition of 7,97,222 shares of the company
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback